Abbott shares jump after approval for diabetes monitor; competitor DexCom crashes on surprise news
September 28, 2017 at 11:48 AM EDT
The Food and Drug Administration approved Abbott's FreeStyle Libre glucose monitoring system, over a year earlier than analysts at Cowen anticipated.
